Info

BloodStream

BloodStream is an entertaining and informational podcast for the bleeding disorders community. Each week, hemophilia patient Patrick James Lynch and former non-profit director Amy Board are joined by advocacy leaders, medical experts, and other guests to discuss the latest news, scientific advancements, policy initiatives, and so much more. Subscribe wherever you listen, or search BloodStream Podcast on YouTube to catch every episode there. Produced by Believe Limited. Presenting sponsor: Takeda.
RSS Feed
BloodStream
2024
April
March
February
January


2023
December
November
October
September
August
July
June
May
April
March
February
January


2022
December
November
October
September
August
July
June
May
April
March
February
January


2021
December
November
October
September
August
July
June
May
April
March
February
January


2020
December
November
October
September
August
July
June
May
April
March
February
January


2019
December
November
October
September
August
July
June
May
April
March
February
January


2018
December
November
October
September
August
July
June
May
April
March
February
January


2017
December
November
October
September
August
July
June
May
April
March
February
January


2016
December
November
October
September
August
July
June


Categories

All Episodes
Archives
Categories
Now displaying: Page 1
Mar 16, 2020

Patrick & Natalie are joined by Ask The Expert’s Amy Board for a health-data driven Like Segment, and the hilarious Zach Anner joins to talk comedy, cerebral palsy, and to share his well-balanced perspective of life.

Zach Anner’s If At Birth You Don’t Succeed

Zach Anner’s YouTube Channel

2020 Teen Impact Awards & Adam Lynch Scholarship

“These startups are innovating the future of healthcare”

Presenting Sponsor: Takeda

Like Segment Sponsor: Genentech

Subscribe to and rate The BloodStream Podcast

Subscribe to and rate The Ask The Expert Podcast

Subscribe to and rate BloodStream Journeys

Connect with BloodStream Media on Facebook

Come with @pjlynch on Twitter




0 Comments
Adding comments is not available at this time.